PharmAthene Inc. (PIP) Stock Quote

Detailed Quote for PharmAthene Inc. (PIP)

After Hours: $ 1.57

0.00 (0.00%)

Volume: 1.85 k

5:15 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

May 13, 2011

Close: 4.08

52 Week Low

December 15, 2011

Close: 1.07

Today

Last Price
1.57

Change $
0.05

Change %
3.29%

Tick
N/A

Bid
1.51

Bid Size
1,900

Ask
1.60

Ask Size
14,500

Open
1.53

High
1.59

Low
1.5288

Prev Close
1.52

Last Trade
4:02

Volume
451.54 k

52 Wk Hi
4.08

52 Wk Low
1.07

Market Cap
75.8 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
48,282,100

EPS (TTM)
-0.55

PE Ratio
N/A

close Exchange Information Listed On NYSE Amex Equities Exchange (AMX) Exchange
AMX

News and Media for PharmAthene Inc. (PIP)

Sector News | Topic News

News for PIP

Wed, Feb 08, 2012

10:38 AM

PharmAthene to Present at the Leerink Swann 2012 Global Healthcare Conference on February 15, 2012 - PR Newswire

Wed, Jan 11, 2012

2:19 PM

PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012 - PR Newswire

Mon, Dec 19, 2011

8:30 AM

Delaware Chancery Court Denies SIGA Technologies' Motion for Reargument - PR Newswire

Tue, Dec 06, 2011

12:39 PM

Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim® - PR Newswire

Mon, Nov 28, 2011

10:10 AM

PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011 - PR Newswire

Wed, Nov 16, 2011

11:37 AM

PharmAthene to Present at the 2011 Chemical and Biological Defense Science and Technology Conference - PR Newswire

Wed, Nov 09, 2011

7:30 AM

PharmAthene Appoints Linda L. Chang Senior Vice President, Chief Financial Officer - PR Newswire

7:30 AM

PharmAthene Reports Third Quarter 2011 Financial and Operating Results - PR Newswire

Fri, Nov 04, 2011

1:59 PM

PharmAthene to Host Third Quarter 2011 Conference Call and Webcast on Wednesday, November 9, 2011 - PR Newswire

Mon, Oct 31, 2011

11:08 AM

PharmAthene Progresses Second Generation rPA Anthrax Vaccine - PR Newswire

Thu, Oct 13, 2011

9:30 AM

PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument - PR Newswire

Wed, Oct 12, 2011

3:46 PM

WMD Research Center Gives the Country's Biopreparedness Effort a "D" for Medical Countermeasures Development and Availability - PR Newswire

Mon, Sep 26, 2011

4:01 PM

PharmAthene Appoints Brian A. Markison to the Company's Board of Directors - PR Newswire

Thu, Sep 22, 2011

4:17 PM

PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court - PR Newswire

Fri, Sep 09, 2011

9:00 AM

PharmAthene Achieves Significant Progress in SparVax(tm) Anthrax Vaccine Program - PR Newswire

Mon, Aug 29, 2011

3:00 PM

NYSE Amex Required Update - PR Newswire

Wed, Aug 17, 2011

12:24 PM

PharmAthene to develop bio-defense program - UPI

Tue, Aug 16, 2011

9:00 AM

Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program - PR Newswire

Wed, Jun 29, 2011

9:00 AM

Research Report on Vertex Pharmaceuticals Inc. and PharmAthene, Inc. - Gaining in the Bio Pharmaceutical Sector - Marketwire

Thu, Mar 31, 2011

8:16 AM

Speculative Biotech Firms Grapple With Difficult Approval Process - Marketwire

More News for PIP >>

Tags for PharmAthene Inc.

Research stocks or mutual funds related to PharmAthene Inc. by keywords or tags. Find companies that have a similar focus to PIP. The keywords below have been associated to PIP by either user submission or electronic means.

pacific stock exchange stock market for beginners pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment stock market trading hours chart patterns pharmaceutical advisory boards stock markets pharma marketing stock market help stock quote stock market beginners pharma manufacturing chemical and biological weapons pharma license chemical biological financial report european pharmaceutical Bioterrorism generic products pharmaceutical cro pharma companies pharma consulting chemical gas stock market history chemical decontamination options trading anthrax detector biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical magazine pharmaceutical consultant chemical protection pharmaceutical manufacturing software stock options chemical weapons pharmaceutical manufacturing charting software the american stock exchange stocks contract pharmaceutical pharmaceutical industry pharmaceutical sale pharmaceutical studies pharmaceutical advances pharmaceutical distributor biological agent detection